By Leonid Schneider, on research integrity, biomedical ethics and academic publishing
Schneider Shorts 28.04.2023 – old American papers in need of fixing, young russian and Iranian researchers in need of helping, French whistleblowers in need of punishing, Austrian anti-aging supplements in need of advertising, with an anti-aging pimp on cocaine, depressive fish in China, cured Israeli soldiers, and finally, retractions in full, in part and not at all.
Schneider Shorts 8.12.2022 – with a harassed nano-fabricator in France, growing pressure on Stanford president, a resigned dean of Weill Cornell, a resigned psychology editor, a Chilean cheater suspended for 2 months, Elon’s monkey torture, stolen fossils kerfuffle, Elisabeth Bik finds an Easter Egg, and as usual, scholarly publishers misbehaving.
Paolo Macchiarini affair: I reproduce the letter Patricia Murray, Raphael Levy, Peter Wilmshurst and myself published in The BMJ on 2 March 2022. I also publish Wilmshurst’s appeal to the UCL leadership.
Videregen, the Liverpool-based company which bought the trachea regeneration patent from UCL, deployed lawyers against the academics Patricia Murray and Raphael Levy, precisely via their employer University of Liverpool. Main issue is the parliamentary submission by Levy and Murray, subject to absolute privilege. Yet Videregen also cites from the confidential notice of suspected research misconduct Murray and Levy submitted in good faith to UCL.
Two somewhat controversial approaches to nanoparticle delivery: the striped nanoparticles by Francesco Stellacci, and the spherical nucleic acids by Chad Mirkin.
For Better Science